Venkat Mali, Ph.D.
About Venkat Mali, Ph.D.
Venkat Mali, Ph.D. - Director, Medicinal Chemistry
Venkat Mali, Ph.D., currently holds the position of Director of Medicinal Chemistry. With a strong background in synthetic organic chemistry, Dr. Mali has extensive experience in the pharmaceutical industry. His role involves overseeing the discovery and development of new medicinal compounds, with a focus on innovative drug discovery and development processes.
Venkat Mali's Journey at AbbVie
During his tenure at AbbVie, Venkat Mali was instrumental in the discovery of ABBV-101, a BTK degrader. This achievement highlights his contributions to advancing therapeutic solutions within significant disease areas. His work at AbbVie showcases his expertise in medicinal chemistry and drug discovery, emphasizing his capability to contribute to groundbreaking developments in the pharmaceutical industry.
Contributions at ChemoCentryx
Venkat Mali, Ph.D., made significant contributions at ChemoCentryx, where he supported the discovery of several small molecule drug candidates. Notably, his efforts led to the FDA approval of TAVNEOS, a medication for patients with autoimmune diseases. Additionally, Dr. Mali was involved in the development of three Phase 2 clinical compounds and one Phase 1 clinical compound, demonstrating his impact on advancing clinical-stage drug pipelines.
Venkat Mali's Academic Background
Venkat Mali earned his Ph.D. in synthetic organic chemistry from the Indian Institute of Chemical Technology, Hyderabad. Following his doctoral studies, he conducted postdoctoral research at the Scripps Research Institute. His academic background provided a solid foundation in chemical synthesis, equipping him with the skills necessary for his later achievements in medicinal chemistry.
Publications and Patents by Venkat Mali
With co-authorship of 48 publications and patents, Venkat Mali, Ph.D., has significantly contributed to scientific literature and intellectual property in the field of medicinal chemistry. His published works and patents underscore his expertise and active involvement in advancing research and development efforts within the pharmaceutical industry.